Last reviewed · How we verify

NCT02996331

Preventing Pressure Ulcers With Repositioning Frequency and Precipitating Factors

Completed NA Last updated 24 February 2021
What this trial tests

NA trial testing 2 hour repositioning in Pressure Ulcer in 2,113 participants. Completed in 11 October 2019.

Timeline
16 May 2017
Primary endpoint
10 October 2019
11 October 2019

Quick facts

Lead sponsorDuke University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment2,113
Start date16 May 2017
Primary completion10 October 2019
Estimated completion11 October 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Duke University

Who can join

Eligibility, any sex, with Pressure Ulcer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether repositioning frequency can be extended for nursing home (NH) residents who are low, moderate, and high risk for pressure ulcer (PrU) development. The investigators will also determine how changes in medical severity interact with changes in risk level and repositioning schedule to predict PrU development. This study will advance knowledge about repositioning frequency and clinically assessed PrU risk-level in relation to medical severity. Outcomes of this research will contribute to future guidelines for more precise preventive nursing practices and refinement of PrU prevention guidelines.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Repositioning for pressure injury prevention in adults.
    Gillespie BM, Walker RM, Latimer SL, Thalib L, et al · · 2020 · cited 40× · PMID 32484259 · DOI 10.1002/14651858.cd009958.pub3
  2. TEAM-UP for quality: a cluster randomized controlled trial protocol focused on preventing pressure ulcers through repositioning frequency and precipitating factors.
    Yap TL, Kennerly SM, Horn SD, Bergstrom N, et al · · 2018 · cited 19× · PMID 29463211 · DOI 10.1186/s12877-018-0744-0
  3. Nursing Assessment of Pressure Injury Risk with the Braden Scale Validated against Sensor-Based Measurement of Movement.
    Kennerly SM, Sharkey PD, Horn SD, Alderden J, et al · · 2022 · cited 13× · PMID 36421654 · DOI 10.3390/healthcare10112330
  4. Characteristics of Nursing Home Resident Movement Patterns: Results from the TEAM-UP Trial.
    Kennerly SM, Sharkey PD, Horn SD, Zheng T, et al · · 2022 · cited 5× · PMID 35195085 · DOI 10.1097/01.asw.0000822696.67886.67
  5. Insight Into the Movement Behaviors of Nursing Home Residents Living With Obesity: A Report of Two Cases.
    Sabol VK, Kennerly SM, Alderden J, Horn SD, et al · · 2020 · cited 5× · PMID 32401731 · DOI 10.25270/wmp.2020.5.1829
  6. The Nursing Home Severity Index and Application to Pressure Injury Risk: Measure Development and Validation Study.
    Yap TL, Horn SD, Sharkey PD, Brooks KR, et al · · 2023 · cited 2× · PMID 36757779 · DOI 10.2196/43130
  7. To Turn or Not to Turn: Exploring Nurses' Decision-Making Processes Concerning Regular Turning of Nursing Home Residents.
    Yap TL, Alderden J, Kennerly SM, Horn SD, et al · · 2021 · cited 1× · PMID 34631970 · DOI 10.1177/23337214211046088
  8. Effect of Varying Repositioning Frequency on Prevention of Pressure Injuries in Nursing Home Residents: TEAM‐UP Cluster‐Randomized Clinical Trial Results
    Yap TL, Horn SD, Sharkey PD, Zheng T, et al · · 2021 · cited 1× · DOI 10.21203/rs.3.rs-717425/v1

Verify or expand the search:

Other recruiting trials for Pressure Ulcer

Currently open trials in the same condition.

Other Duke University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02996331.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing